Top 10 Generic Drug Raw Material & Excipient Suppliers in Netherlands

Robert Gultig

5 January 2026

Top 10 Generic Drug Raw Material & Excipient Suppliers in Netherlands

User avatar placeholder
Written by Robert Gultig

5 January 2026

Introduction:

The pharmaceutical industry in the Netherlands continues to thrive, with a growing demand for generic drug raw materials and excipients. In recent years, the country has become a key player in the global pharmaceutical market, with a focus on high-quality products and innovative solutions. The production volume of generic drug raw materials and excipients in the Netherlands has been steadily increasing, reflecting the country’s strong position in the industry.

Top 10 Generic Drug Raw Material & Excipient Suppliers in Netherlands:

1. DSM – DSM is a leading supplier of generic drug raw materials and excipients in the Netherlands, with a market share of over 20%. The company’s products are known for their high quality and reliability, making them a top choice for pharmaceutical manufacturers.

2. Fagron – Fagron is another key player in the Dutch pharmaceutical industry, specializing in the production of excipients and raw materials for generic drugs. The company’s extensive product range and strong distribution network have contributed to its success in the market.

3. Avantor – Avantor is a global supplier of chemicals and materials for the pharmaceutical industry, with a significant presence in the Netherlands. The company’s innovative products and customer-centric approach have helped it secure a leading position in the market.

4. Merck – Merck is a well-known name in the pharmaceutical industry, with a wide range of products including raw materials and excipients for generic drugs. The company’s commitment to quality and innovation has made it a preferred supplier for many pharmaceutical manufacturers.

5. Lonza – Lonza is a Swiss-based company with a strong presence in the Dutch market for generic drug raw materials and excipients. The company’s expertise in biotechnology and manufacturing processes has set it apart from competitors, making it a top choice for pharmaceutical companies.

6. BASF – BASF is a global leader in the chemicals industry, with a significant presence in the Dutch market for generic drug raw materials and excipients. The company’s focus on sustainability and innovation has helped it maintain a competitive edge in the industry.

7. Evonik – Evonik is a German-based company that supplies a wide range of raw materials and excipients for the pharmaceutical industry in the Netherlands. The company’s strong research and development capabilities have enabled it to introduce new and improved products to the market.

8. Kerry Group – Kerry Group is a multinational food and ingredients company that also supplies raw materials and excipients for the pharmaceutical industry in the Netherlands. The company’s diverse product portfolio and commitment to quality have made it a trusted supplier for pharmaceutical manufacturers.

9. Roquette – Roquette is a French company that specializes in plant-based ingredients, including raw materials and excipients for generic drugs. The company’s sustainable sourcing practices and high-quality products have earned it a strong presence in the Dutch market.

10. Croda – Croda is a UK-based company that supplies specialty chemicals and ingredients for the pharmaceutical industry in the Netherlands. The company’s focus on innovation and collaboration with customers have helped it establish a solid reputation in the market.

Insights:

The Dutch pharmaceutical industry is expected to continue its growth trajectory, driven by increasing demand for generic drugs and innovative solutions. With a strong focus on quality and sustainability, Dutch suppliers of generic drug raw materials and excipients are well-positioned to capitalize on this trend. According to recent statistics, the market size for generic drug raw materials and excipients in the Netherlands is projected to reach $1.5 billion by 2025, reflecting the country’s growing importance in the global pharmaceutical market. As competition intensifies, companies will need to focus on innovation and collaboration to maintain their competitive edge in the industry.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →